Alcidion Group Limited · ASX:ALC
Alcidion — Shareholder Meeting (November 2016)
24 slides from Alcidion's shareholder meeting presentation, Nov 29, 2016
Slide 1: Alcidion Group Limited AGM Presentation
For personal use only Alcidion Group Limited AGM Presentation November 2016 1
Slide 2: Disclaimer
DISCLAIMER Disclaimer For personal use only This presentation has been prepared by Alcidion Group Limited (the "Company"). It does not purport to contain all the information that a prospective investor may require in connection with any potential investment in the Company. You should not treat the c
Slide 3: Corporate snapshot
ASX Ticker ALC Market Capitalisation $69.23 million For personal use only 40% Founders Ownership 15% BlueSky Private Equity 11% Owned by Employees Share Price 11.50c Cash on hand $6+ million Enterprise Value $63 million Shares on Issue 603 million Employees 30 x FTE Revenues FY16 $4 million Cumulati
Slide 4: Investor Relations
For personal use only INVESTOR RELATIONS 4
Slide 5: Top Shareholders
TOP SHAREHOLDERS CONSOLIDATED BY COMMON ADDRESS No Shareholder Shares Percentage 1 Dr Malcolm Pradhan 139,861,782 23.20% For personal use only 2 Mr Raymond Blight & Ms Robyn Morris 100,770,933 16.72% 3 BSPE Medical Technology Pty Ltd 90,863,812 15.07% 4 Allure Capital Pty Ltd 16,717,243 2.77% 5 Dr V
Slide 6: Alcidion Price/Volume Performance
ALCIDION PRICE/VOLUME PERFORMANCE Meeting with WA Health Minister For personal use only $0.14 16 WA Roadshow Millions 14 $0.12 WA Brokers Meet Biotech $0.10 Release of Annual 12 Brian Leedman appointment Report to Shareholders $2.35m MoU with Western Health 10 $0.08 BioShares Presentations Cashflow
Slide 7: Number of ALC Shareholders
NUMBER OF ALC SHAREHOLDERS 1400 For personal use only 1200 1000 800 600 400 200 0 January February March April May June July August September October November 7
Slide 8: Original NRR Shareholders
For personal use only ORIGINAL NRR SHAREHOLDERS ID Name 31/07/2015 27/11/2016 1 KONKERA PTY LTD <KONKERA FAMILY A/C> 7,800,000 - 2 BLU BONE PTY LTD 6,700,000 - 3 KOBIA HOLDINGS PTY LTD 6,700,000 - 4 UPSKY EQUITY PTY LTD <UPSKY INVESTMENT A/C> 6,700,000 - 5 MR JOHN HENRY TOLL <TOLL FAMILY DISCRET A/C
Slide 9: Why Is Digital Health Such an Exciting Investment Opportunity?
WHY IS DIGITAL HEALTH SUCH AN EXCITING INVESTMENT OPPORTUNITY ? For personal use only ● The global population is aging, resulting in a dramatic and unparalleled increase in population, complex patients with multiple co-morbidities. ● The United States spends 18% of GDP on Healthcare, representing ov
Slide 10: Why Is Digital Health Such an Exciting Investment Opportunity?
WHY IS DIGITAL HEALTH SUCH AN EXCITING INVESTMENT OPPORTUNITY ? For personal use only ● The Patient Protection & Affordable Care in 2010, mandated that all US hospitals upgrade their Clinical Information Systems. ● This HITECH Act stipulates that healthcare providers must demonstrate the meaningful
Slide 11: The Stars Are Aligning for Digital Health
THE STARS ARE ALIGNING FOR DIGITAL HEALTH For personal use only ● FDA Regulating the environment. ● The Global Governments are allocating funds to Digital Health: – The United States government has set aside more than $USD20 billion in stimulus funds to implement Electronic Health Records nationwide
Slide 12: Testimonial: Professor Tissa Wijerante
For personal use only “This has skyrocketed the efficiency in patient care as well as the safety” Professor Tissa Wijerante Consulting Neurologist Director of the Stroke & Neuroscience Unit Western Health 12
Slide 13: Testimonial: Jason Whakaari, Western Health
For personal use only “You’ll see nearly all of the clinical, executive and divisional directors walking around with the bed management views on their iPads, and the same with the bed management staff, the quality managers, the NUMs and any staff that help move the patients around.” Jason Whakaari E
Slide 14: Executive Directors
For personal use only EXECUTIVE DIRECTORS Chief Medical Officer Chief Executive Officer Executive Director Prof. Malcolm Pradhan Mr. Ray Blight Mr. Nathan Buzza • Formal qualifications in medicine • Formal qualifications include a Bachelor of • Former founder & CEO of Clinical Middleware complimente
Slide 15: Non-Executive Directors
For personal use only NON-EXECUTIVE DIRECTORS Non-Executive Director Non-Executive Director Non-Executive Director Mr. Brian Leedman Mr. Nick Dignam Mr. Josh Puckridge • Formal qualifications include a Bachelor of • Formal qualifications include a Bachelor of • Formal qualifications include a Bachel
Slide 16: What Does Alcidion Do?
For personal use only WHAT DOES ALCIDION DO ? ● Hospitals are built upon a complex eco-system of disparate Clinical Information Systems. ● Alcidion’s Miya platform integrates disparate Clinical Information Systems to identify emerging clinical risk and push this clinical intelligence to the care tea
Slide 17: What Does Alcidion Do?
For personal use only WHAT DOES ALCIDION DO ? ● The technology is already deployed and operational at: – Western Health. – Northern Territory Health Department. – Tasmania Health. – Royal Melbourne Hospital. ● By providing clinicians with decision support tools and prompting care guidance in accorda
Slide 18: Unique Opportunity To Be Part of the New Digital Health Economy
Unique Opportunity To Be Part of the New Digital Health Economy For personal use only The introduction of the Patient Protection & Affordable Care Act requires US hospitals to adopt Electronic Medical Records or face a reduction in Medicare reimbursements. 18
Slide 19: Experienced Management Team
Experienced Management Team For personal use only “Capable and Experienced Management Team with a strong track record of commercializing healthcare software, including the former CEO & Chairman of the South Australian Health Commission, a Stanford qualified Medical Doctor and a former Ernst & Young
Slide 20: Proven Technology
Proven Technology For personal use only Alcidion’s platform is installed into 11 large tertiary hospitals including Footscray, Sunshine, Williamstown, Royal Darwin & Alice Springs Hospitals and throughout Tasmania. 20
Slide 21: Disruptive Technology Platform
Disruptive Technology Platform For personal use only The platform is at the forefront of medical technology, on the crest of the next generation of healthcare technologies. 21
Slide 22: Strong Growth Platform
Strong Growth Platform For personal use only The business recently secured a $2.35m MoU with Western Health to adopt its Patient Flow Solutions across its three locations. 22
Slide 23: Fully Funded
Fully Funded For personal use only The recent listing of Alcidion on the ASX will see the company fully funded, with $6m in cash and debt free. 23
Slide 24: Questions?
For personal use only QUESTIONS ? 24